Leita frttum mbl.is

Rtt lei ea rng?

er a stva jflagi og loka allri starfsemi til a vernda gamlingja sem eru veikir ea feigir hvort sem er?

Trump forseti gerir sr etta ljst a a gengur ekki a drepa samflaginu til a vernda einhverja srstaka hpa. Samflagi verur a virka. ess vegna verur a einbeita sr a v a finna smituu og setja sttkv en ekki blsa upp sgur um hversu hrilegt s a nokkur sund deyi.

Leiari snska viskiptablainu bendir athyglisvert samhengi:

" lrir miki viku. Fyrstu vibrg rkisstjrna var a loka landamrum, sklum, vinnustum og borgum land eftir land.

Allar rkisstjrnir hafa brugist nokkurn veginn eins og me nokkrum tfum eins og til dmis Svj, en allar fylgdu smu stefnu me v a draga r snertifltum banna kemur veg fyrir tbreislu COVID vrusinn.

Seinni vibrg snrust um hagkerfi. Kauphallirnar brugust vi me alvarlegu falli hlutabrfa. Svo komu skilabo fr fyrirtki eftir fyrirtki um uppsagnir, tilkynningar, lokaar verksmijur og hrmungar llum neytendatengdum atvinnugreinum eins og flugi, veitingasta, hteli, hrgreislu og verslun.

getur skili tta stjrnmlamanna vi a gera mistk barttunni vi heimsfaraldurinn. Spr um mgulega fjlda alvarlega veikra og ltinna eru gnvekjandi. gnin er reifanleg og mannleg og engin rkisstjrn heiminum vill standa handjrnum vi lan borgaranna. Kjsendur munu sna enga miskunn.

En maur verur lka a skilja og vega og meta efnahagslegu gnina sem getur fylgtplitskumkvrunum. Hugsanlega geta slkar kvaranir gert tliti dekkra en vrustbreisla egar jafnvel strfyrirtki fara fjldauppsagnir, lfeyrisskerfi sem ekki halda, sparif urrka upp og skatttekjur minnka hratt og veikja opinberan rekstur.

Plitskar afleiingar strfellds efnahagslegrar lgar eru httuleg, ekki sst fyrir lf og heilsu. Alvarlegar efnahagskreppur valda tmabrum daua.

Lnan milli smitvarna og efnahagslegs tjns er erfi a sj. ess vegna verur n a byrja a ra rangur, sanngirni og horfa til skalegra hrifa nverandi lokunarstefnu.

Corona faraldurinn er nmsferill fyrir alla. Vi vitum samt of lti. En vi ekkjum sumt og getum dregi brabirganiurstur. Tlfrin fr talu, sem tekin er saman af Jennifer Wegerup, frttaritara SVT, talu, er skr. laugardag var tlfri gefin t fyrir 3.200 manns sem hafa ltist, smitair af krna. Mealaldurinn var 78,5 r. 98,9 prsent eirra voru me ara, sumir nokkra, alvarlega undirliggjandi sjkdma. 17 manns undir 50 eru ltnir. Allir hfu ara undirliggjandi veikindi. Enginn undir rtugu hefur ltist. Hj strum meirihluta eirra sem smitast er sjkdmurinn vgur.

Til a setja 3.200 dausfllum samhengi er gott a vita a 50.000 manns mnui deyja talu (7.500 Svj) oftast bland vi elli og sjkdma og stundum af venjulegri flensu. Engin umnnunarastaa og ekkert samflag bjargar llum mannslfum.

Landafri og samflagsuppbygging talu eru aeins frbrugin Evrpu. Landi hefur eldri ba og er ni samband milli kynslanna. En fyrir dauanum er mannflki eins, svo vi skulum gera r fyrir a sjkdmurinn s gn vi alla og a eir sem eru httu a ltast, s sama og talu.

Er a hfilegt a setja alla heilbriga og yngri ba sttkv v skyni a vernda sjka og aldraa? Er ekki betra a gera hi gagnsta og einangra eins og Suur-Kreu skra httuhpa, fjldaprf og setja sem smitast heimastkv, gera skra og krefjast byrgar einstaklinga me a huga a vernda aldrara og lta afganginn af bum starfa og vinna eins og venjulega og koma veg fyrir smit eins og mgulegt er me handvotti og veikindaleyfum?

A halda efnahagslfi og samflagi fram og er einnig vernd, og framhaldi af v, smitvernd ar sem heilsugsla mun ekki virka ef hagkerfi hrynur.

Ein stan fyrir v a ll lnd fara smu tt er lklega s a Kna setti fljtt fordmi og a allir arir gtu ekki gert anna en a fylgja eftir. Vi notum knverskt smitlkan sem Peking-stjrnin tk upp eftir a hafa reynt a leyna skingunni nokkra mnui. Skyndilega vildu yfirvld stjrnvalda sna agerir og lrisrkin, nema Suur-Krea, fylgdu.

vestrnum heimi hefur niurstaan ori hr hrmung fyrir efnahagslfi.

a er brjla a halda fram nverandi lnu. Rkisstjrnin Svj verur smm saman a draga til baka rstafanir og tilmli sem reynast rangurslaus og valda meirihttar efnahagslegu tjni auk ess a taka forystu ESB-hringnum og rsta hin lndin.

Vi erum me tflutningsh hagkerfi en vanmetum ekki mikilvgi og varnarleysi innlendra markaa. Hagkerfi borgarinnar er a mestu leyti kni af flki sem hittist til a bora, umgangast, rstefna, klippa, sj listir og leikhs. Flagsleg fjarlg er banvn gn vi borgina eins og vi ekkjum hana.

Rki getur ekki bra heilt hagkerfi sem er stva. a verur of drt og eyir fljtt mikilvgum hvata fyrir vinnu og fyrirtki egar srhagsmunir og hugmyndafri finna hvort anna.

Hgt er a hgja tbreislu smits me dmi, aldrair og veikir f hjlp vi skingum og umnnun. a er jafn mikilvgt a opna stva efnahagslf."

Singaporefr lka hina leiina og eir nustrax tkum standinu.

Vi slendingar eigum a reyna a finna smituu og einangra en halda allri starfsemi fram sem smitair geta annast. Trump talar um a opna Bandarkin sem fyrst aftur sem ir flug fyrir okkur ef vi getum heft smitleiirnar. Og maur talar ekki um ef einhver jrn finnast sem bta veiruna.

En a er rng lei a frna llu talska samflaginu vegna 3200 manns sem eru nrri ttrir og veikir fyrir af rum sjkdmum egar 50.000 manns deyja hvort sem er hverjum mnui.

Rtt lei er a einbeita sr a v a finna og einangra smituu.


Sasta frsla | Nsta frsla

Athugasemdir

1 Smmynd: Halldr Jnsson

Efst baugi mealaleitinni:

Japan flu drug

A drug developed by Fujifilm Toyama Chemical in Japan is showing promising outcomes in treating at least mild to moderate cases of COVID-19,Live Science previously reported.

The antiviral drug, called Favipiravir or Avigan, has been used in Japan to treat influenza, and last month, the drug was approved as an experimental treatment for COVID-19 infections,Pharmaceutical Technology reported.

So far, reports suggest the drug has been tested in 340 individuals in Wuhan and Shenzhen. "It has a high degree of safety and is clearly effective in treatment," Zhang Xinmin, of China's science and technology ministry, said March 17,The Guardian reported.

The drug, which works by preventing certain viruses from replicating, seemed to shorten the duration of the virus as well as improve lung conditions (as seen in X-rays) in tested patients, though the research has yet to be published in a peer-reviewed science journal.

Chloroquine and hydroxychloroquine

Chloroquine and hydroxychloroquine have been approved by the U.S. Food and Drug Administration for the treatment of malaria, lupus and rheumatoid arthritis, but preliminary research inhumanandprimate cellssuggests that the drugs could effectively treat COVID-19.

A 2005 studyfound that chloroquine could quell the spread of SARS-CoV when applied to infected human cells in culture. SARS-CoV is closely related to the novel coronavirus, SARS-CoV-2, and caused an outbreak of severe acute respiratory syndrome in 2002. Chloroquine disrupts the ability of the SARS-CoV virus to enter and replicate in human cells,Live Science previously reported. The cell culture studies of SARS-CoV-2 revealed that the drug and its derivative hydroxychloroquine undermine the novel virus' replication in a similar way.

Doctors in China, South Korea, France and the U.S. are now giving the drug to some patients with COVID-19 with promising, albeit anecdotal, results so far. The FDA is organizing a formal clinical trial of the drug.

As of Feb. 23, seven clinical trials had been registered in theChinese Clinical Trial Registryto test whether COVID-19 infections could be treated with hydroxychloroquine. In addition, the University of Minnesota is studying whether taking hydroxychloroquine can protect people living with infected COVID-19 patients from catching the virus themselves.

In one heavily referenced study, conducted in France, a small number of patients with COVID-19 received either hydroxychloroquine alone or hydroxychloroquine in combination with an antibiotic called azithromycin. The authors reported that detectable concentrations of SARS-CoV-2 fell significantly faster in the study participants than coronavirus patients at other French hospitals who did not receive either drug. In six patients also given azithromycin, this promising effect appeared to be amplified.

However,the CDC notedthat the small, non-randomized study "did not assess clinical benefit[s]" associated with the treatment; in other words, the study did not probe whether the treated patients were more likely to recover and survive their illness. Additionally, the agency advised that doctors should be cautious when giving either drug to patients with chronic disease, such as kidney failure, and especially those "who are receiving medications that might interact to cause arrhythmias."

A failed Ebola drug

A Gilead Sciences drug that was originally tested in people with Ebola, remdesivir, is being repurposed to see if it can effectively treat COVID-19.

The drug was found not to be effective in Ebola, but in lab studies, it has proven effective at inhibiting the growth of similar viruses, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). In a petri dish, remdesivir can prevent human cells from becoming infected with SARS-CoV-2,according to a letter published in the journal Naturein February.

The Food and Drug Administration has currently approved use of remdesivir for compassionate use, meaning only patients with severe COVID-19 disease can be approved for treatment. In other countries, requirements to receive remdesivir may be less stringent.

Five clinical trials in China and the U.S. are currently evaluating whether remdesevir can reduce complications or shorten the disease course in COVID-19 patients, the medical news siteSTAT reported.

Many doctors are excited about the drug's potential.

"There's only one drug right now that we think may have real efficacy," Bruce Aylward of the World Health Organization said last month, as reported by STAT. "And that's remdesivir."

George Thompson, an infectious disease specialist at UC Davis Medical Center who treated an early, severe case of COVID-19,told Science magazinethat their patient got better after getting the drug, about 36 hours after diagnosis. The doctors initially thought the patient would die, Thompson said.

However, such anecdotal evidence can't demonstrate effectiveness, and the lab has yet to analyze blood samples to show that the patient's clinical improvement following the administration of remdesivir coincided with a drop in viral load (concentration of viral particles). On the flip side, a study posted to the preprint databasemedRXivlooked at three patients treated with remdesivir. The study, which was not peer-reviewed, found no clear time-dependent relationship between getting the drug and seeing improvements in symptoms. The patients also experienced rectal bleeding, elevated liver enzymes, vomiting and nausea, which could potentially be tied to the drug.

Another quandary is that antiviral drugs generally work better the earlier patients get them, but because remdesivir is not FDA-approved for general use, only patients with the most severe, and late-stage, disease, qualify for its use in clinical trials, Thompson told Science.

On Sunday (March 22), Gilead Sciences announced that they were temporarily halting compassionate use of remdesivir, due to "overwhelming demand." Instead, they are focusing on approving previously submitted requests and streamlining the process, while directing people to enroll in clinical trials,STAT reported.

Halldr Jnsson, 24.3.2020 kl. 15:25

2 Smmynd: mar Geirsson

Blessaur Halldr.

gamall srt munt upplifa skrif n hr a ofan.

Ef vi tkum Trump t r jfnunni, standa eftir, ekki rlfur, heldur Svar.

Rkisstjrn krata sem kaus a ltafaraldurinn ganga yfir.

g spi v a Svar muni upplifa sn fyrstu rttarhld umlandr rm 200 r, vitnar menn sem eru s gagnvart mannfelli.

trir eim svo mjg a skautar framhj a veiran er rtt a byrja, og verur verri me hverri stkkbreytingunni.

Persnulega held g a hafir smu tr og mennirnir sem hittust yfir glasi og gum mat, lgu drg af skilvirkni, og skilduakkrat ekkert v a eir voru hengdir fyrir viki. nkvmni essarar lsingar felst a sumir af eim voru egar dauir.

Halldr minn, ert strri en a a gera lti r drepsttinni, treystu frekar sem svrin eiga seinna komi.

Sama hva mrg ffl segja r anna, flk er ekki tilbi a deyja fyrirfrjlshyggju ausins.

Flk vill lifa.

Og egar a er lifandi, spir a eftirmlin. Til dmis a halda hagkerfum heimsins gangandi.

Halldr, guir nir segi r a urfir a deyja svo auur eirra skerist ekki, er a bara svo a dag, hlustar enginn .

Okei, Bjarni stti lagi en hann er a grafa Sjlfstisflokkinn eitt skipti fyrir allt.

a er sorglegt, v hann er hfur.

Kveja a austan.

mar Geirsson, 24.3.2020 kl. 16:05

3 Smmynd: Halldr Jnsson

Vertu n ekki a blanda prvat kommerinu nu inn etta mar minn.

Mr snist a heimurinn s a fara til andskotans ef ekki finnst lei til a drepa ennan djfuls vrus niur. a verkefni er nmer 1,2 og 3 , nkvmlega ekkert af v sem essi rkisstjrn er a dla t mun hjlpa, bara piss skinn.

Lkning verur a finnast og a strax. a verur a taka einhverja sjansa sem er ekki venjan a gera. a er allt undir. essu verur a linna. Finna ll smit strax og einangra, gefa meul og reyna a halda starfsemi og atvinnu lfi.

Loka hlisleitendur strax. ALLA. Burt me

Halldr Jnsson, 24.3.2020 kl. 21:42

4 Smmynd: mar Geirsson

Blessaur Halldr.

g er nkvmlega ekki a v.

a fnkerar ekkert samflag egar drepstt gengur laus, eir sem halda anna munu reka sig .

Hvort sem a er Trump ea snskir kratar.

a er ekkert til sem heitir knverskt mtel smitvrnum, a a einangra smit er aldagmul afer, getur til dmis lesi um a Biblunni varandi holdsveika sem urftu a yfirgefa samflag flks og lifa uppfr v einangrun.

talskar borgir beittu essum rum svo snemma sem smildum og svo framvegis.

gfa okkar er a flk skuli blanda plitk etta og halda a a s eitthva til sem heitir knverskt ea Trumpskt eins og nafni minn virist vera binn a f heilann.

En kei, g var a stra r me v a henda inn oralaginu "frjlshyggju ausins", en a verur alltaf a hafa nokkra ttiprjna svona athugasemdum til a hreifa vi flki.

Veit ekki hvort athugasemdin virka, en eins og afstaa n var skynsamleg pistli num, var hn mjg svo skynsamleg andsvari nu.

etta er kjarninn;

"Lkning verur a finnast og a strax. a verur a taka einhverja sjansa sem er ekki venjan a gera. a er allt undir. essu verur a linna. Finna ll smit strax og einangra, gefa meul og reyna a halda starfsemi og atvinnu lfi. ".

Og a sem kallar knverskasttkvna er eitt slkt meal.

a sem kom mr vart var a hn vri framkvmanleg svona maurabi eins og inaarsvi Kna er, en fyrst a var hgt ar, er etta hgt annars staar.

Og mia vi frttir, virast bi Spnverjar og talir ra vi essa aferafri a myndi vissulega ganga betur ef au tkju sm fasisma etta. Msslni hefi lti skjta brotlega fri egar heill rkis og jar vri undir.

Mli reyndar ekki me v, en rkynjun, a a geta ekki teki dauans alvru alvarlega, er einn helsti bandamaur veirunnar.

ann bandamann arf a handtaka, er restin eins og a drekka vatn.

Og efnahagurinn mun svo blmsta n.

Kveja a austan.

mar Geirsson, 24.3.2020 kl. 22:51

5 Smmynd: Halldr Jnsson

g er farinn a vera skuggalega sammla gamla kommanum a austan. Kannski er skynsemin a sameina okkur vert okkar gmlu barnatr og gmlu kreddur?

Halldr Jnsson, 24.3.2020 kl. 23:23

Bta vi athugasemd

Hver er summan af tu og ellefu?
Nota HTML-ham

Höfundur

Halldór Jónsson
Halldór Jónsson

verkfræðingur, flugdellukall, tennis-og badmintonspilari

-ekki góður í neinu af þessu-

Heimsknir

Flettingar

  • dag (8.4.): 571
  • Sl. slarhring: 612
  • Sl. viku: 5964
  • Fr upphafi: 2839698

Anna

  • Innlit dag: 476
  • Innlit sl. viku: 4696
  • Gestir dag: 416
  • IP-tlur dag: 386

Uppfrt 3 mn. fresti.
Skringar

Eldri frslur

Innskrning

Ath. Vinsamlegast kveiki Javascript til a hefja innskrningu.

Hafu samband